Novadaq Reports Financial Results for the First Quart...(6) ...),Health
Navigation Links
Novadaq Reports Financial Results for the First Quarter of 2008
Date:5/12/2008
6)
--------------------------
Total shareholders' equity 29,352,504 33,989,175
--------------------------
34,714,219 41,720,114
--------------------------
--------------------------
CONSOLIDATED STATEMENTS OF LOSS AND
COMPREHENSIVE LOSS AND DEFICIT
(expressed in U.S. $)
Unaudited
Three months Three months
ended ended
March 31, March 31,
2008 2007
$ $
--------------------------
Revenues
Product sales 2,414,585 1,427,424
Service revenue 358,077 -
--------------------------
Total revenues 2,772,662 1,427,424
Cost of sales 1,468,191 748,062
--------------------------
Gross profit 1,304,471 679,362
--------------------------
Operating expenses
Sales and marketing 2,784,126 2,216,885
Research and development 1,612,091 1
'/>"/>
| SOURCE Novadaq Technologies Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
2. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
3. Novadaq announces third quarter 2007 conference call and webcast
4. Novadaq to present at Piper Jaffray Healthcare Conference
5. Novadaq to present at BMO Healthcare Conference
6. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
7. Novadaqs SPY System receives clearance for use in organ transplant surgery
8. Novadaq Data Presented at 2008 Society of Thoracic Surgeons Meeting
9. NOVADAQs SPY System to be Featured During Live Broadcast of Robotic Surgery
10. Novadaq to present at Cowen Healthcare Conference
11. Novadaq to hold fiscal 2007 year-end and fourth quarter results conference call and webcast
Post Your Comments:
(Date:1/8/2009)...bad cholesterol more effectively than Zocor , ... nearly a year of review, U.S. health officials sa...of the controversial cholesterol-lowering drug Vyt...aid there was no significant difference in carotid...and patients taking the drug Zocor. , But, the ...
(Date:1/8/2009).... 8 Hanger Orthopedic Gr...at throughout the fourth quarter of 2008 it acquir...cky Mountain Orthotic-Prosthetics Center, Riessen,...Coast Orthotics & Prosthetics, and Orthopedic ...dd patient care centers to existing markets in Mai...
(Date:1/8/2009)...Jan. 8 Medivation, Inc.,..., M.D., president and chief,executive officer, wi...re,Conference on Wednesday, January 14, at 10:00 ... in San Francisco. , Dr. Hung will provide ...pment programs for Dimebon for Alzheimer,s and Hun...
(Date:1/8/2009).... 8 A new educational W...dance on drugs, biological products and medical de...Quality,s Centers for Education and Research on Th...of more than a dozen leading research centers nati...formation Network ( CHAIN ) http://www.chainonlin...
Breaking Medicine News(10 mins):Health News:FDA Backs Cholesterol Drug Vytorin 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2[0] FDA Backs Cholesterol Drug Vytorin[0] Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue[0] Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference[0] AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics
...at should be welcome news for tens of thousands of...ing homes are modernising and entering into tie-up... the growing trend in medical tourism. Half a doz...e up in a year, in addition to scores of smaller g...
...mical component extracted from the cannabis, or ma...ach cramping after eating, according to a study pr... the American College of Gastroenterology. The stu...and placebo on colonic motility and sensation in h...
...rs working in Iraq admit that more than half of th... medical equipment and more experienced staff and ...sim Al Sheibani and colleagues say that as the vio...y is that they cannot treat many of the victims. ...
...ding to the researchers in the U.S., a supplement ...ction of stress linked to metabolic syndrome, a co... diabetes and heart disease. Metabolic syndrome c...on, and unstable glucose and insulin metabolism an...
Other Medicine News:Health News:Agra Hospitals Modernise to Promote Medical Tourism 2Health News:Cinnamon extract in reduction of risk of metabolic syndrome 2(Date:1/6/2009)...r maintaining a healthy immune system , , PURCH...shed study in Nutrition and Cancer (60(5), 643-6... Osaka, Japan has shown that AHCC (Active Hexose C...creasing the number of dendritic cells (DCs). DCs ...r presenting foreign substances to other immune sy...
(Date:1/6/2009)...wswire/ -- Cequent Pharmaceuticals, a pioneer in t...ased treatments to prevent and treat human disease...d a successful toxicology study of its candidate C... targeting the primary oncogene (beta-catenin, CTN...is an inherited gastrointestinal disease that caus...
(Date:1/5/2009)...ewswire-FirstCall/ -- Micromet, Inc.,(Nasdaq: M...l, proprietary,antibodies for the treatment of ca...des an outlook on key events anticipated for the y...n update on its research and development,programs...16, 2009: Update on several preclinical BiTE antib...
(Date:12/29/2008)...wire-USNewswire/ -- The winner of the 2008 Award f...ounced today by Dr. Peter G. Goldschmidt, Presiden... , , The winner of the annual award was the ...-- for its best practice " IND Regulatory and Mo...nhanced human subjects protection, 2) improved dat...
Breaking Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 52008 Human Research Protection Award Recipients Announced 2Depressed Moms Kids at Higher Injury Risk 7613 1Depressed Moms Kids at Higher Injury Risk 7613 2Fry Construction Is Featured in Key Industry Publication 7610 1Fry Construction Is Featured in Key Industry Publication 7610 2InvoiceCHECK Cuts Prescription Benefit Waste 7606 1InvoiceCHECK Cuts Prescription Benefit Waste 7606 2DenteMax Forms Business Alliance With MEDILINQ 7602 1DenteMax Forms Business Alliance With MEDILINQ 7602 2[0] Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells[2] Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference[2] Micromet Key Events for 2009[0] 2008 Human Research Protection Award Recipients Announced
...lood Pressure in Obese and,Non-Obese Hypertensive ...all/ -- Forest,Laboratories, Inc. today presented ...oled analysis of nebivolol, a selective beta,1-blo...review by,the U.S. Food and Drug Administration (F...he two clinical studies show that,nebivolol demons...
... and 40/25 mg/day and Amlodipine +,Benazepril 5/20...,Hypertension Twenty-Second Annual Scientific Meet...- New data,presented today at the American Society... Meeting (ASH 2007) in Chicago,demonstrated that t...medoxomil/hydrochlorothiazide) was associated with...
Other Medicine Technology:Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 2Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 3Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8...tome Semi-Automatic Tissue Sectioning System has m...ctioning system. Researchers from around the globe...ir fresh and fresh fixed tissue sectioning needs f...issue Sectioning Systems, the biological viability...
...3000 Deluxe Sectioning System provides a versatile...ant tissues. The 3000 employs a vibrating blade p...or embedding. The creation of artifacts, the alte...tivities, and other deleterious effect inherent in...
The Vibratome comes standard with a square vice mounting device. These specimen blocks are utilized for mounting specimens and placing in the Vibratome holding vice. The blocks are annodized black
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades.
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |